Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-12

FDA Approved: VIGABATRIN FOR ORAL SOLUTION — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application to Camber Pharmaceuticals for Vigabatrin for oral solution, enabling a generic oral form of Vigabatrin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin for oral solution (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN FOR ORAL SOLUTION (VIGABATRIN)